Table 85: erythema Table 86: peeling/decortication Table 87: drying Table 88: pruritus Table 89: scorching hot/twinge The safety evaluation that carries out according to erythema: on baseline, 32 experimenters (91.4%) have erythema to a certain degree.This disease is considered to slightly to moderate in most of experimenters (28 experimenters, 80%), and it is rubescent that 4 experimenters (11.4%) have significantly (3 grades).In the 6th week, in 4 experimenters (11.8%), there is not erythema, in 30 experimenters (88.2%), there are slight or moderate erythema, yet do not observe 3 grades of erythema.Observed maximum erythema scoring improves in 7 experimenters with respect to baseline in research process, in 15 experimenters, does not change, and worsens 13 experimenters.Whole erythema scoring improves in 11 experimenters with respect to baseline, do not changed by examination at 22, in 2 experimenters, worsens
IV Glutathione IV glutathione is administered directly into the bloodstream, completely bypassing digestion and absorption barriers
Proglucagon is subsequently processed by the prohormone convertases 1, 2 and 3 50 to produce, among other products, the 29-amino-acid-long GCG (in human, positions 5381, PSCK2) and the 30-amino-acid-long GLP-1 736 (positions 98127, PSCK1), which are the focus of this work
Kaempferol activates the Nrf2/SLC7A11/GPX4 pathway, boosting antioxidant defenses and reducing neuronal ferroptosis in OGD/R-induced damage, showing promise for CIRI treatment, though further animal studies are needed (Yuan et al., 2021)
